|
Volumn 82, Issue 18, 2014, Pages 1572-1573
|
Immune therapy for pharmacoresistant epilepsy: Ready to go?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTICONVULSIVE AGENT;
AUTOANTIBODY;
AZATHIOPRINE;
CORTICOSTEROID;
CORTICOTROPIN;
CYCLOPHOSPHAMIDE;
IMMUNOGLOBULIN;
MEMBRANE ANTIGEN;
METHYLPREDNISOLONE;
MONOCLONAL ANTIBODY;
MYCOPHENOLIC ACID;
N METHYL DEXTRO ASPARTIC ACID RECEPTOR;
PREDNISONE;
RITUXIMAB;
ANTICONVULSANT THERAPY;
AUTOIMMUNE DISEASE;
BRAIN DISEASE;
CELL MEMBRANE;
CORTICOSTEROID THERAPY;
DISEASE DURATION;
DISEASE SEVERITY;
DRUG EFFICACY;
DRUG SAFETY;
EDITORIAL;
EPILEPSY;
EPILEPTOGENESIS;
HUMAN;
IMMUNE SYSTEM;
IMMUNOSUPPRESSIVE TREATMENT;
IMMUNOTHERAPY;
INFANTILE SPASM;
PATHOPHYSIOLOGY;
PHARMACORESISTANT EPILEPTIC SYNDROME;
PLASMA;
PLASMAPHERESIS;
PRIORITY JOURNAL;
PSYCHOSIS;
SCHIZOPHRENIA;
SEIZURE;
TREATMENT RESPONSE;
EPILEPSY;
HUMANS;
IMMUNOTHERAPY;
|
EID: 84902169451
PISSN: 00283878
EISSN: 1526632X
Source Type: Journal
DOI: 10.1212/WNL.0000000000000391 Document Type: Editorial |
Times cited : (7)
|
References (10)
|